Ekso Bionics prices $5.852 million private placement
Evidence notes
- Ekso Bionics announced a private placement expected to generate gross proceeds of approximately $5.852 million before fees and expenses.
- The company said the financing would support working capital and general corporate purposes as it continued commercializing exoskeleton products for medical and industrial use.
- The event followed a difficult 2025 operating year and served as a balance-sheet support step rather than a product milestone.
Company context
Ekso Bionics develops wearable robotic exoskeletons for rehabilitation, mobility assistance and industrial use cases. Its systems use powered assistance to support human movement rather than replacing the worker or patient with a standalone robot.